Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 14 June 2022, 12:00 HKT/SGT
Share:
    

Source: Olympus
Olympus to Use 100% Renewable Electricity at R&D and Manufacturing Sites in Japan
Leads to 70% renewable energy use on a global level and marks significant progress towards achieving net zero carbon emissions by 2030

TOKYO, June 14, 2022 - (ACN Newswire) - Olympus Corporation ("Olympus" - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announces that from April 2022, the company has begun to exclusively source 100% of the electricity used at its major R&D and manufacturing sites in Japan from renewable sources.

As a result, CO2 emissions from Olympus Group facilities in Japan will be reduced by approximately 40,000 tons per year. The percentage of the Olympus Group's total electricity use* in fiscal 2023 (ending March 2023) from renewable energy sources is expected to substantially increase from approximately 14% in the previous fiscal year to approximately 70%.

- Transition to Renewable Energy Usage across the Olympus Group (Facilities in Japan and Overseas)
FY2020 11.7%
FY2021 12.7%
FY2022 (estimate) 14% (approx.)
FY2023 (estimate) 70% (approx.)
*Excluding recently acquired companies, certain service offices, and certain sales offices.

Olympus has set a goal of achieving net zero CO2 emissions from its site operations by 2030, as part of its commitment to achieving environmentally responsible business growth and creating a sustainable society. This is a key goal in line with our ESG materiality targets focused on the theme of a "carbon neutral society and circular economy."

The company has already introduced a wide range of initiatives to reduce CO2 emissions. This includes the use of 100% renewable energy at some manufacturing sites in Europe and the United States, the installation of solar power generation facilities at some manufacturing sites in Japan, and support of the recommendations made by the Task Force on Climate-related Financial Disclosures (TCFD)*.

To achieve its carbon neutral goal, Olympus will continue to optimize manufacturing processes and promote energy-saving measures, is committed to further accelerate the shift to renewable energy sources across the company, thereby contributing to the decarbonization of society on a global level.

About Olympus

Olympus is passionate about creating customer-driven solutions for the medical, life sciences, and industrial equipment industries. For more than 100 years, Olympus has focused on making people's lives healthier, safer and more fulfilling by helping to detect, prevent, and treat disease; furthering scientific research; and ensuring public safety. Olympus is headquartered in Tokyo, Japan, with more than 30,000 employees worldwide in nearly 40 countries and regions. For more information, visit www.olympus-global.com and follow our global Twitter account: @Olympus_Corp (https://twitter.com/olympus_corp).

Olympus Contact
Communications
Contact Olympus: https://www.olympus-global.com/products/contact/

*News release "Olympus Targets Carbon Neutrality by 2030 - Adds Carbon Neutrality and Circular Economy to its ESG Materiality and Supports the Recommendations of the Task Force on Climate-Related Financial Disclosures":
https://www.olympus-global.com/news/2021/contents/nr02125/nr02125_00001.pdf


Topic: Press release summary
Source: Olympus

Sectors: Environment, ESG, Alternative Energy, BioTech, Healthcare & Pharm, Funds & Equities
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Olympus
Sept 30, 2024 14:00 HKT/SGT
Olympus Launches VISERA S, a New Imaging Platform
Sept 20, 2024 14:00 HKT/SGT
Olympus Launches New 4K Camera Head for Urological Endoscopy
June 12, 2024 10:00 HKT/SGT
Olympus Enhances Innovation Capabilities by Expanding R&D to Hyderabad, India
Mar 27, 2024 14:00 HKT/SGT
NTT and Olympus Begin World's First Joint Demonstration Experiment of Cloud Endoscopy System
Jan 24, 2024 14:00 HKT/SGT
Olympus Closes the Acquisition of Korean Gastrointestinal Stent Company, Taewoong Medical Co., Ltd
Dec 11, 2023 10:00 HKT/SGT
Olympus Named to Dow Jones Sustainability World Index for Three Consecutive Years
Dec 7, 2023 10:00 HKT/SGT
Vesica AI Selected as Winner of Inaugural Olympus Asia Pacific Innovation Program
Nov 30, 2023 10:00 HKT/SGT
Olympus's Net-Zero Targets Approved by SBTi
Oct 6, 2023 20:00 HKT/SGT
Olympus Names Dr. John de Csepel as Chief Medical Officer
July 20, 2023 10:00 HKT/SGT
Olympus to Launch Development Support Project in Kenya for the Diagnosis of Gastrointestinal Diseases
More news >>
 News Alerts
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: